954220-47-4 Usage
Uses
Used in Pharmaceutical Industry:
4-piperidin-4-ylpyrimidine is utilized as a key intermediate in the synthesis of various pharmaceuticals for the development of drugs targeting a range of diseases and conditions. Its unique structure allows for the creation of diverse medicinal compounds with potential therapeutic benefits.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 4-piperidin-4-ylpyrimidine serves as a valuable component in the design and synthesis of novel drug candidates. Its presence in these compounds can influence their biological activities, making it an essential tool for researchers exploring new treatment options.
Used in Organic Synthesis:
4-piperidin-4-ylpyrimidine is employed as a building block in organic synthesis, contributing to the creation of a variety of organic compounds with different applications. Its structural features facilitate the formation of complex molecules with specific properties, broadening its utility in chemical research and development.
Used in Biological Activity Studies:
Due to its inherent biological activities, 4-piperidin-4-ylpyrimidine is used in studies aimed at understanding its potential therapeutic properties. Researchers in the pharmaceutical and chemical industries investigate its interactions with biological systems to explore its efficacy in treating specific conditions or diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 954220-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,4,2,2 and 0 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 954220-47:
(8*9)+(7*5)+(6*4)+(5*2)+(4*2)+(3*0)+(2*4)+(1*7)=164
164 % 10 = 4
So 954220-47-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H13N3/c1-4-10-5-2-8(1)9-3-6-11-7-12-9/h3,6-8,10H,1-2,4-5H2
954220-47-4Relevant articles and documents
Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists
Pasternak, Alexander,Goble, Stephen D.,Vicario, Pasquale P.,Di Salvo, Jerry,Ayala, Julia M.,Struthers, Mary,DeMartino, Julie A.,Mills, Sander G.,Yang, Lihu
, p. 994 - 998 (2008/09/19)
This report describes replacement of the 4-(4-fluorophenyl)piperidine moiety in our CCR2 antagonists with 4-heteroaryl piperidine and 4-(carboxyphenyl)-piperidine subunits. Some of the resulting analogs retained potency in our CCR2 binding assay and had i
